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Abstract – The base-catalyzed addition of 4-nitrobutanoates 6 to 
N-tert-butanesulfinyl imines 8 under solvent-free reaction conditions proceeded 
with high face diastereoselectivity. The resulting β-nitroamine derivatives 9 were 
easily transformed into 6-substituted piperidine-2,5-diones 11 upon removal of the 
sulfinyl group with concomitant δ-lactam formation and functional group 
transformation under Nef reaction conditions. 
INTRODUCTION 
Substituted piperidine-2,5-diones are versatile building blocks in organic synthesis because they can be 
transformed very easily into substituted piperidin-3-ols with high control of the stereochemistry. It is 
known that the piperidine ring is widely represented in many natural products and can exhibit broad range 
of biological activities.1 Particularly, systems with the piperidin-2-ol skeleton having substituents at 
2-position2 and 6-position3 are of great pharmacological interest. For instance, (+)-febrifugine (1) is a 
natural product isolated from Dichroa febrifuga,4 a plant used in traditional Chinese medicine to treat 
malaria (Figure 1). A synthetic propanoic acid derivative 2, with a 3-hydroxyl-2-piperidinyl unit, showed 
a potent in vitro activity as a GABA receptor binder, similar to that displayed by baclofen.5 Several 
2,6-disubstituted piperidin-3-ols have been isolated from the African savanna plant, Prosopis africana. 
Among them, (+)-prosophylline (3) displays antibiotic and anesthetic properties (Figure 1).6  
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Figure 1 
 
Most of the enantioselective syntheses of substituted piperidin-3-ols reported until today are based on the 
chiral pool synthesis using amino acid and sugar derivatives as starting materials.7 Other stereoselective 
syntheses included as key steps nucleophilic additions of organomagnesium compounds to chiral oximes8  
and enzymatic resolution of racemic compounds.2,9 Continuing our interest in the use of 
N-tert-butanesulfinyl imines10 as electrophiles, we envisioned a straightforward synthesis of 6-substituted 
piperidin-2,5-diones, based on the diastereoselective aza-Henry reaction of methyl or ethyl 
4-nitrobutanoate and these chiral imines.11 Our retrosynthentic analysis for the preparation of target 
6-substituted piperidin-2,5-diones is depicted on Scheme 1. 
 
 
Scheme 1 
RESULTS AND DISCUSSION 
Methyl and ethyl 4-nitrobutanoate (6a and 6b, respectively) were prepared in reasonable yields (42 and 
47%, respectively) from the corresponding acrylate 4 and an excess of nitromethane (5) in the presence of 
0.1 equivalents of sodium hydroxide at 0 to 23 ºC for 12 h. The reaction is performed without an 
additional solvent. In spite of working with an excess of nitromethane (5), compounds resulting from 
double conjugate addition 7 were also isolated as undesirable side reaction products (Scheme 2). 
   
 
Scheme 2 
 As depicted in Scheme 1, our approach to the synthesis of target 6-substituted piperidine-2,5-diones 
commenced with the diastereoselective aza-Henry reaction of methyl or ethyl 4-nitrobutanoate (6a or 6b, 
respectively) with N-tert-butanesulfinyl imines 8. These chiral imines 8 were easily accessible from 
(R)-tert-butanesulfinamide and the corresponding aldehyde.12 First, imine 8a (derived from 
3-phenylpropanal) was taken as the model compound in order to determine the optimal reaction 
conditions to carry out the coupling of nitro compounds 6 with chiral imines 8. Sodium bicarbonate has 
recently been used successfully in our group as a promoter of the condensation of nitromethane (5) and 
nitroethane with sulfinyl imines 8.10t The reaction of 3 equivalents of methyl 4-nitrobutanoate (6a) with 
8a in the presence of 2 equivalents of sodium bicarbonate at 60 ºC for 3 days led to the expected 
aza-Henry product 9aa in relatively low yield (Table 1, entry 1). Ethyl 4-nitrobutanoate (6b), under the 
same reaction conditions, produced 9ab even in lower yield (Table 1, entry 2). Very low yield was also 
obtained when the reaction was performed under sonication for 7 h, using the same reaction mixture of 6a, 
8a and sodium bicarbonate (Table 1, entry 3). Interestingly, yield was significantly improved (from 37 to 
80%) when the coupling of 6a and 8a was performed in the presence of 0.2 equivalents of sodium 
hydroxide as a base at 40 °C for 24 h (Table 1, entry 4). Fortunately, the sodium hydroxide promoted 
reaction of imine 8a with ethyl 4-nitrobutanoate (6b) led to expected adduct 9ab in a satisfactory 76% 
isolated yield (Table 1, entry 5). In order to broaden the scope of the sodium hydroxide promoted 
aza-Henry reaction, we applied the optimized conditions depicted in Table 1, entries 4 and 5, to 
N-tert-butanesulfinyl imines 8b and 8c. Thus, the reaction of imine 8b derived from isovaleraldehyde 
with methyl and ethyl 4-nitrobutanoate (6) gave compounds 9ba and 9bb in 69 and 50% yield, 
respectively (Table 1, entries 6 and 7). Meanwhile, the reactions of nitro compounds 6 with chiral imine 
8c derived from nonanal produced the expected adducts 9ca and 9cb in near 50% yield (Table 1, entries 8 
and 9). In these reactions, two stereogenic centers are generated, and diastereomeric ratios shown on 
Table 1 refer to the face selectivity. Regarding the second stereogenic center, an almost 1:1 mixture of 
epimers were always obtained, due probably to the reaction conditions (prolonged reaction times in the 
presence of a base), considering that an acidic proton remains in 9, so epimerization could take place 
rapidly. Nucleophilic additions of nitro compounds 6 to chiral imines 8 takes place with relatively high 
diastereoselectivity, diastereomeric ratios ranging in all cases from 87:13 (Table 1, entry 5) to 98:2 (Table 
1, entry 6). The stereochemical pathway of these nucleophilic additions to chiral sulfinyl imines was 
previously studied in depth by us10t and others.13 It was always found that in the case of chiral imines 8 
with R configuration at the sulphur atom, the attack of the nucleophile occurs predominantly to the Si-face 
of the imine, so the configuration assigned to the newly created stereogenic center bonded to the nitrogen 
atom in compounds 9 is based in this assumption.  
 
 Table 1.  Aza-Henry reaction of chiral imines 8 with alkyl 4-nitrobutanoates 6a 
   Compound 9  
Entry Reaction Conditions  R R’ No. (Yield)b drc 
1 8a, 6a (3 equiv), NaHCO3 (2 equiv), 60 ºC, 3 d Ph(CH2)2 Me 9aa (37%) ND 
2 8a, 6b (3 equiv), NaHCO3 (2 equiv), 60 ºC, 3 d Ph(CH2)2 Me 9ab (<10%) ND 
3 8a, 6a (3 equiv), NaHCO3 (2 equiv), )))), 7 h Ph(CH2)2 Me 9aa (<10%) ND 
4 8a, 6a (3 equiv), NaOH (0.2 equiv), 40 ºC, 24 h Ph(CH2)2 Me 9aa (80%) 95:5 
5 8a, 6b (3 equiv), NaOH (0.2 equiv), 40 ºC, 24 h Ph(CH2)2 Et 9ab (76%) 87:13
6 8b, 6a (3 equiv), NaOH (0.2 equiv), 40 ºC, 24 h i-PrCH2 Me 9ba (69%) 98:2 
7 8b, 6b (3 equiv), NaOH (0.2 equiv), 40 ºC, 24 h i-PrCH2 Et 9bb (50%) 95:5 
8 8c, 6a (3 equiv), NaOH (0.2 equiv), 40 ºC, 24 h Me(CH2)7 Me 9ca (45%) 92:8 
9 8c, 6b (3 equiv), NaOH (0.2 equiv), 40 ºC, 24 h Me(CH2)7 Et 9cb (49%) 90:10
a All the reactions were carried out with 0.2 mmol of aldimine 8. b Yield was determined for isolated 
compound after column chromatography. c The diastereomeric ratio was determined by 1H NMR of the 
crude reaction mixture and refers to the facial selectivity. 
 
Compounds of type 9 were previously prepared by García Ruano, Cid and co-workers, following a 
slightly different strategy. They performed first the nucleophilic addition of nitromethane (5) to a chiral 
N-p-toluenesulfinyl imine, and subsequently, the DBU-promoted Michael addition of the resulting 
β-nitroamino derivative to the corresponding acrylate. These compounds were later transformed into the 
6-substituted 5-nitropiperidin-2-ones as shown in Scheme 3.14  
 
 
 
Scheme 3 
 
 We found also of interest, to reach compounds 9 through a one-pot multicomponent assembling of 
nitromethane (5), chiral imines 8 and acrylates 4. Benefits of the multicomponent processes use to include 
decreased operational costs associated with time and labor. For that reason we studied first this reaction 
with chiral aldimine 8a as a model imine. Different reaction conditions were applied (stoichiometry, 
temperature, reaction time, base, reagents addition order, solvent) and the highest yield of the expected 
adducts 9aa and 9ab were obtained when the imine 8a reacted first with 3 equivalents of nitromethane (5) 
in the presence of 0.5 equivalents of sodium hydroxide at 40 ºC for 24 h, and after that, 4 equivalents of 
the corresponding acrylate 4 were added maintaining the reaction mixture at the same temperature for 24 
additional hours. The methyl ester derivative 9aa was obtained in 30% yield and the ethyl derivative 9ab 
in 35% yield (Scheme 4). The here described one-pot methodology does not seem to be superior to the 
multistep strategy previously commented.  
 
 
Scheme 4 
 
Removal of the tert-butanesulfinyl group in compounds 9 was achieved under acidic conditions. Further 
treatment of the initially formed ammonium chloride salt with an aqueous saturated solution of sodium 
bicarbonate produced the free amine, which underwent rapid intramolecular cyclization to give 
6-substituted 5-nitropiperidin-2-one 10 as a mixture of diastereoisomers in an almost 3:1 ratio, 
trans-isomer being the major component of the mixture. Pure diastereoisomers were obtained after 
column chromatography purification. In general, yields were slightly higher in the case of the methyl 
ester derivatives (Table 2). Finally, compounds 10, as a diastereomeric mixture, were transformed into 
piperidine-2,5-diones 11 under typical Nef reaction conditions. First treatment with sodium methoxide in 
methanol to generate the corresponding nitronate at room temperature, followed by addition of a 
methanolic solution of sulfuric acid and final hydrolysis at low temperature. After that, the expected dione 
11 was formed along with the corresponding dimethyl acetal, since the protonation of the nitronate was 
performed in a mixture of methanol and water. A second hydrolysis at 100 ºC in water under acidic 
conditions of the residue resulting after removing of volatile solvents gave the expected 
piperidine-2,5-dione 11 as a single isomer (Table 2).  
 
 Table 2.  Synthesis of 6-substituted piperidine-2,5-diones 11 from compounds 9 
 Starting Compound 9  Compound 10 Compound 11 
Entry R R’ No.  R No. (Yield)a R No. (Yield)b
1 Ph(CH2)2 Me 9aa  Ph(CH2)2 10a (40%) 
Ph(CH2)2 11a (66%) 
2 Ph(CH2)2 Et 9ab  Ph(CH2)2 10a (23%) 
3 i-PrCH2 Me 9ba  i-PrCH2 10b (43%) 
i-PrCH2 11b (55%) 
4 i-PrCH2 Et 9bb  i-PrCH2 10b (47%) 
5 Me(CH2)7 Me 9ca  Me(CH2)7 10c (60%) 
Me(CH2)7 11c (50%) 
6 Me(CH2)7 Et 9cb  Me(CH2)7 10c (50%) 
a Combined yield was determined for the mixture of diastereoisomers after column chromatography 
purification. b Yield was determined for isolated compounds after column chromatography. 
 
In summary, enantioenriched 6-substituted piperidine-2,5-diones 11 were prepared in few synthetic 
operations from commercially available starting materials. The methodology presented here comprised as 
key steps a diastereoselective addition of a 4-nitrobutanoate to a chiral sulfinyl imine, and a Nef reaction 
for the transformation of the nitro group into ketone. Studies are currently in progress trying to find 
reaction conditions for the stereoselective transformation of 6-substituted piperidine-2,5-diones 11 into 
2-substituted piperidin-3-ols 12 and 2,6-disubstituted piperidin-3-ols 13 (Scheme 5), compounds of 
potential biological activity.   
 
 
Scheme 5 
 
EXPERIMENTAL 
All chemicals were commercially available (Acros, Aldrich). TLC was performed on Merck silica gel 60 
F254, using aluminum plates and visualized with phosphomolybdic acid (PMA) stain. Chromatographic 
purification was performed by flash chromatography using Merck silica gel 60 (0.040-0.063 mm) and 
 hexane/EtOAc as eluent. Low-resolution electron impact (EI) mass spectra were obtained at 70eV on 
Agilent GC/MS-5973N apparatus equipped with a HP-5MS column (Agilent technologies, 30 m × 0.25 
mm) and high resolution mass spectra (HRMS-ESI) were obtained on a Waters LCT Premier XE 
apparatus equipped with a time of flight (TOF) analyzer and the samples were ionized by ESI techniques 
and introduced through an ultra-high pressure liquid chromatograph (UPLC) model Waters ACQUITY H 
CLASS.  IR spectra were measured (film) with a Nicolet Impact 510 P-FT Spectrometer. NMR spectra 
were recorded with a Bruker AC-300 using CDCl3 as the solvent and TMS as internal standard. Optical 
rotations were measured on a Perkin Elmer 341 polarimeter. Starting aldimines 8a,15 8b16 and 8c17 were 
prepared according to the procedures reported in the literature from (R)-tert-butanesulfinamide and the 
corresponding aldehyde. 
 
Preparation of 4-nitrobutanoates 6. General procedure. 
To a solution of NaOH (20 g, 0.5 mmol) in nitromethane (1.525 g, 1.3 mL, 25 mmol) was added the 
corresponding acrylate 4 (5 mmol) at 0 ºC. The reaction mixture was stirred for 12 h and the system was 
allowed to reach room temperature. Then, the resulting mixture was hydrolyzed with H2O (20 mL) and 
extracted with EtOAc (3 × 15 mL). The organic layer was washed with brine (2 × 10 mL), dried over 
anhydrous MgSO4 and evaporated (15 Torr). The resulting residue was purified by distillation under 
vacuum to give pure products 6. Yields are given in Scheme 2. Physical and spectroscopic data follow. 
Methyl 4-nitrobutanonate (6a)18. Colourless oil; bp 120-122 ºC (2,4 mbar); Rf 0.45 (hexane/EtOAc: 
3/1); IR ν (film) 2991, 2951, 1731, 1548, 1436, 1372, 1200, 1171 cm-1; 1H NMR (300 MHz, CDCl3) 
δ 4.49 (2H, t, J = 6.6 Hz, CH2), 3.71 (3H, s, Me), 2.48 (2H, t, J = 6.8 Hz, CH2), 2.40-2.21 (2H, m, CH2); 
13C NMR (75 MHz, CDCl3) δ 172.3 (C), 74.3 (CH2), 51.9 (Me), 30.2, 22.3 (CH2); LRMS (EI) m/z 116 
(M+-MeO, 35%), 100 (9), 88 (11), 69 (10), 59 (100). 
Ethyl 4-nitrobutanonate (6b)19. Colourless oil; bp 123-125 ºC (2,4 mbar); Rf 0.46 (hexane/EtOAc: 3/1); 
IR ν (film) 2983, 2946, 2908, 1728, 1550, 1435, 1376, 1177, 1027 cm-1; 1H NMR (300 MHz, CDCl3) 
δ 4.49 (2H, t, J = 6.6 Hz, CH2), 4.16 (2H, q, J = 7.1 Hz, CH2), 2.47 (2H, t, J = 6.8 Hz, CH2), 2.32 (2H, 
quint, J = 6.8 Hz, CH2), 1.27 (3H, t, J = 7.1 Hz, Me); 13C NMR (75 MHz, CDCl3) δ 171.8 (C), 74.3, 60.9, 
30.5, 22.4 (CH2), 14.1 (Me); LRMS (EI) m/z 116 (M+-MeO, 35%), 100 (9), 88 (11), 69 (10), 59 (100). 
 
Preparation of β-nitroamine derivatives 9 from nitrobutanoates 6 and chiral imines 8. General 
procedure. 
A mixture of the corresponding nitrocompound 6 (6.0 mmol), NaOH (16 mg, 0.4 mmol), and the 
corresponding N-tert-butanesulfinyl imine 8 (2.0 mmol) was stirred at 40 ºC for 24 h. The resulting 
mixture was hydrolyzed with H2O (15 mL) and extracted with EtOAc (3 × 15 mL). The organic layer was 
 washed with brine (2 × 10 mL), dried over anhydrous MgSO4, and evaporated (15 Torr). The residue was 
purified by column chromatography (silica gel) to yield pure compounds 9. Yields are given in Table 1. 
Physical and spectroscopic data follow. 
(4R*,5R,RS)-Methyl N-(tert-butanesulfinyl)-5-amino-4-nitro-7-phenylheptanoate (9aa). Mixture of 
diastereoisomers (1:1); yellow oil; Rf 0.31 (hexane/EtOAc: 1/1); IR ν (film) 2947, 2927, 2868, 1734, 
1546, 1454, 1437, 1364, 1174, 1052, 749, 700 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.35-7.10 (10H, m, 
ArH), 5.00-4.91 (1H, m, CH), 4.90-4.82 (1H, m, CH), 4.32 (1H, d, J = 8.6 Hz, NH), 4.27 (1H, d, J = 9.5 
Hz, NH), 3.69 (3H, s, Me), 3.68 (3H, s, Me), 3.64-3.46 (2H, m, CH2), 2.97-2.77 (2H, m, CH2), 2.77-2.56 
(2H, m, CH2), 2.54-2.19 (8H, m, 4 × CH2), 1.95-1.78 (4H, m, 2 × CH2) , 1.31 [9H, s, Me3C], 1.28 [9H, s, 
Me3C]; 13C NMR (75 MHz, CDCl3) δ 172.3, 140.2 (C), 128.6, 128.4, 128.3, 126.3, 90.6, 89.6, 58.5, 57.8 
(CH), 56.8, 56.7 (C), 51.9 (Me), 35.6, 32.4, 32.0, 31.8, 30.2, 29.6, 26.1, 25.0 (CH2), 22.8, 22.7 (Me); 
LRMS (EI) m/z 264 [M+-Ph(CH2)2-Me, 33%], 232 (11), 231 (16), 218 (25), 217 (58), 207 (12), 185 (27), 
183 (19), 158 (15), 143 (37), 141 (16), 139 (28), 133 (21), 132 (29), 129 (22), 128 (20), 115 (26), 91 
(100), 77 (20), 65 (16), 55 (21); HRMS (ESI) calcd for C18H29N2O5S (M+H) 385.1797, found 385.1791. 
 (4R*,5R,RS)-Ethyl N-(tert-butanesulfinyl)-5-amino-4-nitro-7-phenylheptanoate (9ab). Mixture of 
diastereoisomers (1:1); yellow oil; Rf 0.28 (hexane/EtOAc: 1/1); IR ν (film) 2981, 2958, 2918, 1731, 
1547, 1455, 1368, 1241, 1182, 1047, 700 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.36-7.07 (10H, m, ArH), 
4.93 (1H, ddd, J = 9.0, 6.2, 2.5 Hz, CH), 4.87 (1H, dt, J = 6.9, 4.2 Hz, CH), 4.31 (1H, d, J = 8.6 Hz, NH), 
4.24 (1H, d, J =  9.5 Hz, NH), 4.13 (2H, q, J = 7.1 Hz, CH2), 4.12 (2H, q, J = 7.1 Hz, CH2), 3.66-3.43 
(2H, m, 2 × CH), 2.95-2.74 (2H, m, CH2), 2.76-2.53 (2H, m, CH2), 2.52-2.15 (7H, m, 3 × CH2, CHH), 
2.14-1.97 (1H, m, CHH), 1.95-1.77 (3H, m, CH2, CHH), 1.73-1.58 (1H, m, CHH), 1.30 [9H, s, Me3C], 
1.27 [9H, s, Me3C], 1.24 (6H, t, J = 7.2 Hz, 2 × Me); 13C NMR (75 MHz, CDCl3) δ 171.9, 140.3 (C), 
128.6, 128.4, 128.3, 126.3, 90.6, 89.6 (CH), 60.9, 60.8 (CH2), 58.5, 57.8 (CH), 56.8, 56.6 (C), 35.7, 32.4, 
32.0, 31.8, 30.4, 29.7, 26.1, 25.0 (CH2), 22.8, 22.7, 14.1 (Me); LRMS (EI) m/z 313 [M+-Me2C=CH2-Et, 
1%], 182 (47), 157 (20), 144 (14), 143 (100), 141 (25), 129 (32), 128 (28), 115 (20), 111 (13), 91 (67); 
HRMS (ESI) calcd for C19H31N2O5S (M+H) 399.1954, found 399.1941. 
(4R*,5R,RS)-Methyl N-(tert-butanesulfinyl)-5-amino-7-methyl-4-nitrooctanoate (9ba). Mixture of 
diastereoisomers (1:1); yellow oil; Rf 0.30 (hexane/EtOAc: 1/1); IR ν (film) 3193, 2957, 2929, 2870, 
1736, 1548, 1438, 1173, 1028 cm-1; 1H NMR (300 MHz, CDCl3) δ 4.99-4.90 (1H, m, CH), 4.86-4.77 (1H, 
m, CH), 4.19 (1H, d, J = 9.1 Hz, NH), 4.15 (1H, d, J = 9.9 Hz, NH), 3.71 (3H, s, Me), 3.70 (3H, s, Me), 
3.67-3.56 (2H, m, CH), 2.60-2.34 (6H, m, 3 × CH2), 2.33-2.20 (1H, m, CHH), 2.20-2.09 (1H, m, CHH), 
1.88-1.70 (2H, m, CH2), 1.55-1.42 (2H, m, CH2), 1.34-1.28 (2H,m, 2 × CH), 1.26 [9H, s, Me3C], 1.25[9H, 
s, Me3C], 0.93 (3H, d, J = 0.9 Hz, Me), 0.92 (3H, d, J = 0.9 Hz, Me), 0.90 (3H, d, J = 1.9 Hz, Me), 0.89 
(3H, d, J = 1.9 Hz, Me); 13C NMR (75 MHz, CDCl3) δ 172.4, 172.3 (C), 91.1, 90.0, 57.8 (CH), 56.8 (C), 
 56.7 (CH), 56.6 (C), 52.0, 51.9 (Me), 42.6, 39.3, 30.5, 29.7, 26.0, 25.0 (CH2), 24.3, 24.2 (CH), 23.4, 23.0, 
22.8, 22.7, 21.3, 21.0 (Me); LRMS (EI) m/z 280 (M+-C4H8, 1%), 153 (29), 143 (15), 138 (11), 111 (100), 
97 (83), 84 (13), 83 (19), 82 (19), 69 (18), 55 (27); HRMS (ESI) calcd for C14H29N2O5S (M+H) 337.1797, 
found 337.1790. 
(4R*,5R,RS)-Ethyl N-(tert-butanesulfinyl)-5-amino-7-methyl-4-nitrooctanoate (9bb). Mixture of 
diastereoisomers (1:1); yellow oil; Rf 0.31 (hexane/EtOAc: 1/1); IR ν (film) 3218, 2958, 2870, 1732, 
1546, 1365, 1181, 1051 cm-1; 1H NMR (300 MHz, CDCl3) δ 5.00-4.90 (1H, m, CH), 4.88-4.78 (1H, m, 
CH), 4.25-4.78 (6H, m, 2 × NH, 2 × CH2),  3.71-3.55 (2H, m, 2 × CH), 2.62-2.18 ( 10H, m, 5 × CH2),  
1.87-1.72 (2H,  m, 2 × CH), 1.56-1.38 (2H, m, CH2), 1.35-1.16 [24H, m, 2 × Me3C, 2 × Me] 1.01-0.84 
(12H, 4 × Me); 13C NMR (75 MHz, CDCl3) δ 172.0, 171.9 (C), 91.1, 89.9 (CH), 60.9, 60.8 (CH2), 57.7 
(CH), 56.7 (C), 56.6 (CH), 56.5 (C), 42.5, 39.3, 30.6, 29.9, 26.0, 25.0 (CH2), 24.2, 24.1 (CH), 23.3, 23.0, 
22.7, 22.6, 21.2, 21.0, 14.1 (Me); LRMS (EI) m/z 335 (M+-Me, 1%), 216 (38), 185 (10), 170 (56), 169 
(71), 157 (20), 141 (100), 124 (13), 123 (94), 113 (47), 111 (29), 99 (44), 95 (40), 71 (67), 67 (37), 60 
(16), 55 (53); HRMS (ESI) calcd for C15H31N2O5S (M+H) 351.1954, found 351.1950. 
(4R*,5R,RS)-Methyl N-(tert-butanesulfinyl)-5-amino-4-nitrotridecanoate (9ca). Mixture of 
diastereoisomers (1:1); pale yellow oil; Rf 0.40 (hexane/EtOAc: 1/1); IR ν (film) 3242, 2953, 2925, 2925, 
2855, 1736, 1547, 1056, 733 cm-1; 1H NMR (300 MHz, CDCl3) δ 4.97-4.78 (2H, m, 2 × CH), 4.23 (1H, d, 
J = 8.7 Hz, NH), 4.14 (1H, d, J = 8.3 Hz, NH), 3.71 (3H, s, Me), 3.71 (3H, s, Me), 3.64-3.46 (2H, m, 2 × 
CH), 2.61-2.15 (8H, m, 4 × CH2), 1.61-1.44 (8H, m, 4 × CH2), 1.40-1.14 [38H, m, 10 × CH2,  2 × Me3C], 
0.89 (6H, t, J = 6.6 Hz, 2 × Me); 13C NMR (75 MHz, CDCl3) δ 172.4 (C), 90.8, 89.7, 59.4, 58.6 (CH), 
56.7, 56.6 (C), 52.0, 51.9 (Me), 33.8, 31.8, 30.4, 29.7, 29.3, 29.1, 29.0, 26.1, 25.9, 25.8 (CH2), 22.8, 22.7 
(Me), 22.6 (CH2), 14.05 (Me); LRMS (EI) m/z 317 (M+-C2H3O3, 3%), 270 (17), 256 (16), 238 (19), 224 
(16), 208 (21), 196 (17), 187 (19), 140 (17), 110 (34), 97 (33), 96 (57), 95 (24), 85 (16), 83 (44), 82 (100), 
81 (33), 80 (17), 79 (17), 71 (20), 69 (42), 68 (30), 67 (42), 64 (46), 59 (35), 57 (55), 56 (44), 55 (82), 54 
(67), 53 (25); HRMS (ESI) calcd for C18H37N2O5S (M+H) 393.2423, found 393.2418. 
(4R*,5R,RS)-Ethyl N-(tert-butanesulfinyl)-5-amino-4-nitrotridecanoate (9cb). Mixture of 
diastereoisomers (1:1); colourless oil; Rf 0.41 (hexane/EtOAc: 1/1); IR ν (film) 2957, 2925, 2856, 1734, 
1547, 1365, 1181, 1053 cm-1; 1H NMR (300 MHz, CDCl3) δ 4.97-4.78 (2H, m, CH), 4.27-4.02 (6H, m, 2 
× NH, 2 × CH2), 3.61-3.46 (2H, m, 2 × CH), 2.59-2.18 (10H, m, 5 × CH2), 1.64-1.41 (6H, m, 3 × CH2), 
1.38-1.13 [44H, 10 × CH2, 2 × Me, 2 × Me3C], 0.88 (6H, t, J = 6.7 Hz, 2 × Me); 13C NMR (75 MHz, 
CDCl3) δ 171.9 (C), 90.8, 89.6 (CH), 60.9, 60.8 (CH2), 59.3, 58.5 (CH), 56.6, 56.5 (C), 33.7, 31.7, 29.8, 
29.3, 29.2, 29.1, 29.0, 28.9, 26.1, 25.8, 25.7, 25.0 (CH2), 23.0, 22.7, 22.6 (Me), 22.5 (CH2), 14.1, 14.0 
(Me); LRMS (EI) m/z 335 (M+-C4H8-Me, 1%), 187 (18), 170 (11), 143 (20), 140 (20), 129 (50), 113 (19), 
110 (24), 100 (49), 97 (30), 96 (43), 95 (31), 90 (24), 83 (35), 82 (42), 81 (42), 71 (22), 70 (14), 69 (55), 
 68 (17), 67 (39), 64 (36), 63 (18), 57 (63), 56 (37), 55 (100), 54 (27), 53 (16); HRMS (ESI) calcd for 
C19H39N2O5S (M+H) 407.2580, found 407.2573. 
 
Preparation of β-nitroamine derivatives 9aa and 9ab from nitromethane 5, acrylates 4 and chiral 
imine 8a. General procedure. 
A mixture of NaOH (6 mg, 0.15 mmol), nitromethane (55 mg, 0.049 mL, 0.9 mmol) and the chiral imine 
8a (71 mg, 0.3 mmol) was stirred at 40 ºC for 24 h. After that, the excess of nitromethane (5) is removed 
under vacuum (15 Torr). To the resulting residue the corresponding acrylate 4 (1.2 mmol) was added and 
the reaction mixture was stirred at 40 ºC for additional 24 h. Then, the resulting mixture was hydrolyzed 
with H2O (10 mL) and extracted with EtOAc (3 × 10 mL). The organic layer was washed with brine (2 × 
10 mL), dried over anhydrous MgSO4 and evaporated (15 Torr). The residue was purified by column 
chromatography (silica gel, hexane/EtOAc) to yield pure compounds 9aa and 9ab. Yields are given in 
Scheme 4. Physical and spectroscopic data are given above. 
 
Preparation of 6-substituted-5-nitropiperidin-2-ones 10. General procedure. 
To a solution of the corresponding β-nitroamino derivative 9 (0.5 mmol) in THF (0.5 mL) was added 
dropwise a 6M solution of HCl (0.25 mL, 1.5 mmol) at 0 ºC. The reaction mixture was stirred at this 
temperature for 4 h and after that basified with saturated aqueous solution of NaHCO3. Then stirring was 
continued at room temperature for 20 min. Then, the resulting mixture was extracted with EtOAc (3 × 10 
mL). The organic layer was washed with brine (2 × 10 mL), dried over anhydrous MgSO4 and evaporated 
(15 Torr). The residue was purified by column chromatography (silica gel, hexane/EtOAc) to yield pure 
compounds 10. Yields are given in Table 2. Physical and spectroscopic data follow. 
(5S,6R)-5-Nitro-6-(2-phenylethyl)piperidin-2-one trans-(10a). White solid; mp 110-112 ºC 
(hexane/CH2Cl2); [α]20D +71 (c 0.79, CH2Cl2); Rf 0.25 (hexane/EtOAc: 1/2); IR ν (KBr) 3182, 3025, 2918, 
2858, 1656, 1555, 1348, 1349, 802, 747, 698 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.41-7.08 (5H, m, 
ArH), 6.30 (1H, s, NH), 4.71-4.47 (1H, m, CH), 4.25-3.97 (1H, m, CH), 2.91-2.75 (1H, m, CHH), 
2.76-2.63 (1H, m, CHH), 2.63-2.41 (3H, m, CH2, CHH), 2.41-2.25 (1H, m, CHH), 2.00-1.82 (2H, m, 
CH2); 13C NMR (75 MHz, CDCl3) δ 169.7, 139.4 (C), 128.9, 128.2, 126.7, 82.7, 54.0 (CH), 36.3, 31.2, 
27.7, 23.8 (CH2); LRMS (EI) m/z 248 (M+, 0.5%), 202 (22), 201 (100), 143 (13), 105 (13), 97 (59), 92 
(16), 91 (96), 69 (11), 65 (11), 55 (14); HRMS (ESI) calcd for C13H17N2O3 (M+H) 249.1239, found 
249.1227. 
(5R,6R)-5-Nitro-6-(2-phenylethyl)piperidin-2-one cis-(10a). White solid; mp 108-113 ºC 
(hexane/CH2Cl2); [α]20D +85 (c 1.04, CH2Cl2); Rf 0.12 (hexane/EtOAc: 1/2); IR ν (KBr) 3187, 3070, 2941, 
2922, 1655, 1540, 1405, 747, 704 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.40-7.14 (5H, m, ArH), 6.84 (1H, 
 s, NH), 4.87 (1H, dd, J = 9.7, 4.5 Hz, CH), 3.86-3.68 (1H, m, CH), 2.94-2.60 (3H, m, CH2, CHH), 
2.60-2.38 (2H, m, CH2), 2.30-2.14 (1H, m, CHH), 1.89 (2H, dd, J = 14.8, 7.6 Hz, CH2); 13C NMR (75 
MHz, CDCl3) δ 170.7, 139.5 (C), 128.7, 128.3, 126.6, 80.8, 53.0 (CH), 33.2, 31.4, 27.2, 22.9 (CH2); 
LRMS (EI) m/z 248 (M+, 1%), 202 (24), 201 (100), 143 (16), 105 (11), 97 (63), 92 (14), 91 (93), 69 (14), 
55 (17); HRMS (ESI) calcd for C13H17N2O3 (M+H) 249.1239, found 249.1229. 
(5S,6R)-6-Isobutyl-5-nitropiperidin-2-one trans-(10b). White solid; mp 127-129 ºC (hexane/CH2Cl2); 
[α]20D +49 (c 0.78, CH2Cl2); Rf 0.21 (hexane/EtOAc: 1/3); IR ν (KBr) 3193, 3074, 2957, 2927, 2868, 
1657, 1555, 1406, 1375, 1353, 779 cm-1; 1H NMR (300 MHz, CDCl3) δ 6.48 (1H, s, NH), 4.51 (1H, dt, J 
= 6.8, 4.8 Hz, CH), 4.13 (1H, ddd, J = 9.8, 6.2, 2.0 Hz, CH), 2.63-2.50 (3H, m, CH2, CHH), 2.50-2.41 
(1H, m, CHH), 2.39-2.28 (1H, m, CHH), 1.83-1.63 (1H, m, CH), 1.54 (1H, ddd, J = 14.5, 9.3, 5.3 Hz, 
CHH), 1.37 (1H, m, J = 13.7, 9.2, 4.4 Hz, CHH), 0.98 (3H, d, J = 6.6 Hz, Me), 0.95 (3H, d, J = 6.6 Hz, 
Me); 13C NMR (75 MHz, CDCl3) δ 170.0 (C), 83.3, 52.5 (CH), 43.8, 27.6 (CH2), 24.2 (CH), 23.6 (CH2), 
23.1, 21.3 (Me); LRMS (EI) m/z 157 (M+-C3H7, 1%), 153 (44), 138 (16), 112 (13), 111 (100), 97 (96), 83 
(15), 82 (15), 69 (13), 55 (16); HRMS (ESI) calcd for C9H17N2O3 (M+H) 201.1239, found 201.1229. 
(5S,6R)-5-Nitro-6-octylpiperidin-2-one trans-(10c). White solid; mp 96-99 ºC (hexane/CH2Cl2); [α]20D 
+44 (c 0.93, CH2Cl2); Rf 0.38 (hexane/EtOAc: 1/3); IR ν (KBr) 3203, 2919, 2848, 1656, 1556, 1405, 
1352, 793, 626 cm-1; 1H NMR (300 MHz, CDCl3) δ 6.49 (1H, s, NH), 4.56 (1H, dt, J = 11.1, 5.5 Hz, CH), 
4.06 (1H, td, J = 7.6, 1.8 Hz, CH), 2.63-2.40 (3H, m, CH2, CHH), 2.39-2.28 (1H, m, CHH), 1.61-1.56 
(2H, m, CH2), 1.48-1.44 (1H, m, CHH), 1.37-1.27 (11H, m, CHH, 5 × CH2), 0.88 (3H, t, J = 6.9 Hz, Me); 
13C NMR (75 MHz, CDCl3) δ 170.0, 82.8, 54.5 (CH), 34.5, 31.7, 29.2, 29.1, 29.05, 27.6, 24.8, 23.8, 22.6 
(CH2), 14.0 (Me); LRMS (EI) m/z 210 (M+-NO2, 7%), 143 (13), 124 (37), 111 (100), 97 (52), 83 (13), 82 
(13), 56 (22); HRMS (ESI) calcd for C13H25N2O3 (M+H) 257.1865, found 257.1853. 
(5R,6R)-5-Nitro-6-octylpiperidin-2-one cis-(10c). White solid; mp 99-103 ºC (hexane/CH2Cl2); [α]20D 
+84 (c 0.44, CH2Cl2); Rf 0.23 (hexane/EtOAc: 1/3); IR ν (KBr) 3198, 2918, 2850, 1660, 1537, 1411, 
1346, 807 cm-1; 1H NMR (300 MHz, CDCl3) δ 6.35 (1H, s, NH), 4.98-4.80 (1H, m, CH), 3.88-3.70 (1H, 
m, CH), 2.85-2.61 (1H, m, CHH), 2.57-2.40 (2H, m, CH2), 2.28 (1H, ddd, J = 15.6, 9.7, 7.4 Hz, CHH), 
1.64-1.48 (2H, m, CH2), 1.46-1.14 (12H, m, CHH, 6 × CH2), 0.88 (3H, t, J = 6.9 Hz, Me); 13C NMR (75 
MHz, CDCl3) δ 170.6, 80.7, 54.1 (CH), 31.7, 31.6, 29.2, 29.1, 29.05, 27.2, 25.5, 23.0, 22.6 (CH2), 14.05 
(Me); LRMS (EI) m/z 210 (M+-NO2, 23%), 208 (15), 143 (51), 112 (13), 98 (15), 97 (100), 96 (14), 69 
(17), 56 (17), 55 (34); HRMS (ESI) calcd for C13H25N2O3 (M+H) 257.1865, found 257.1857. 
 
Preparation of 6-substituted piperidine-2,5-diones 11. General procedure. 
To a solution of the corresponding nitropiridinone 10 (0.2 mmol) in MeOH (0.5 mL) was added dropwise 
a 1M solution of NaOMe in MeOH (0.3 mL, 0.3 mmol) at room temperature ºC. The reaction mixture 
 was stirred at this temperature for 2 h and after that, it was cooled down to -50 ºC. To the resulting 
reaction mixture was added first a 1M solution of H2SO4 in MeOH (0.6 mL, 0.6 mmol) and after 10 min, 
H2O (1.0 mL). The reaction mixture was allowed to reach room temperature, basified with saturated 
aqueous solution of NaHCO3, extracted with EtOAc (3 × 10 mL), dried over anhydrous MgSO4 and 
evaporated (15 Torr). The resulting residue was suspended in H2O and then a 1M solution of H2SO4 in   
H2O (0.02 mL, 0.02 mmol) was added. The reaction mixture was stirred at 100 ºC for 3 h and after that it 
was cooled down to room temperature, basified with saturated aqueous solution of NaHCO3 and extracted 
with EtOAc (3 × 10 mL). The organic layer was washed with brine (2 × 10 mL), dried over anhydrous 
MgSO4 and evaporated (15 Torr). The resulting white solid was purified by column chromatography 
(silica gel, hexane/EtOAc) to yield pure compounds 11. Yields are given in Table 2. Physical and 
spectroscopic data follow. 
(S)-6-(2-Phenylethyl)piperidine-2,5-dione (11a). White solid; mp 99-102 ºC (hexane/CH2Cl2); [α]20D 
+29 (c 1.02, CH2Cl2); Rf 0.24 (hexane/EtOAc: 1/3); IR ν (KBr) 3193, 2957, 2927, 1717, 1663, 1417, 
1318, 749, 703 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.33-7.25 (2H, m, ArH), 7.24-7.15 (3H, m, ArH), 
6.76 (1H, s, NH), 3.90-3.74 (1H, m, CH), 2.79-2.69 (2H, m, CH2), 2.69-2.62 (4H, m, 2 × CH2), 2.25-2.12 
(1H, m, CHH), 2.10-1.98 (1H, m, CHH); 13C NMR (75 MHz, CDCl3) δ 206.1, 172.2, 139.9 (C), 128.7, 
128.4, 126.5, 60.1 (CH), 35.3, 34.2, 31.1, 29.0 (CH2); LRMS (EI) m/z 217 (M+, 100 %), 134 (12), 132 
(27), 117 (21), 113 (66), 98 (15), 91 (78), 84 (56); HRMS (ESI) calcd for C13H16NO2 (M+H) 218.1181, 
found 218.1172. 
(S)-6-Isobutylpiperidine-2,5-dione (11b). White solid; mp 136-139 ºC (hexane/CH2Cl2); [α]20D +23 (c 
0.23, CH2Cl2); Rf 0.21 (hexane/EtOAc: 1/3); IR ν (KBr) 3203, 2957, 2927, 2868, 1719, 1659, 1426, 1314 
cm-1; 1H NMR (300 MHz, CDCl3) δ 6.37 (1H, s, NH), 3.95-3.76 (1H, m, CH), 2.70-2.66 (4H, m, 2 × 
CH2), 1.88-1.65 (2H, m, CH2), 1.65-1.45 (1H, m, CH), 0.97 (3H, d, J = 6.0 Hz, Me), 0.94 (3H, d, J = 5.9 
Hz, Me); 13C NMR (75 MHz, CDCl3) δ 206.5, 172.0 (C), 59.2 (CH), 41.5, 35.0, 29.1 (CH2), 24.3 (CH), 
23.1, 21.2 (Me); LRMS (EI) m/z 141 (M+-CO, 6 %), 126 (6), 112 (9), 86 (26), 84 (100), 57 (9); HRMS 
(ESI) calcd for C9H16NO2 (M+H) 170.1181, found 170.1173. 
(R)-6-Octylpiperidine-2,5-dione (11c). White solid; mp 83-85 ºC (hexane/CH2Cl2); [α]20D +47 (c 0.60, 
CH2Cl2); Rf 0.31 (hexane/EtOAc: 1/3); IR ν (KBr) 3222, 2917, 2849, 1717, 1669, 1420, 1328, 724 cm-1; 
1H NMR (300 MHz, CDCl3) δ 6.26 (1H, s, NH), 3.89-3.74 (1H, m, CH), 2.76-2.61 (4H, m, 2 × CH2), 
1.89-1.64 (2H, m, CH2), 1.30-1.23 (12H, m, 6 × CH2), 0.88 (3H, t, J = 6.9 Hz, Me); 13C NMR (75 MHz, 
CDCl3) δ 206.2, 172.0 (C), 60.9 (CH), 35.3, 32.9, 31.8, 29.3, 29.2, 29.1, 29.0, 25.0, 22.6 (CH2), 14.1, 
(Me); LRMS (EI) m/z 225 (M+, 1 %), 142 (13), 84 (100), 56 (10); HRMS (ESI) calcd for C13H24NO2 
(M+H) 226.1807, found 226.1798. 
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